(*) EU CE Mark Date: 2020. 06.22.
(*) USA Approval Date: 2020. 04.10.
>Plexiform Neurofibromas (PN)
Company
Generic Name: Selumetinib
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 7
Patent>UpDate: 2021. 07.20.
RTM
RTM Web-Site